Selectis Health (GBCS) Gains from Sales and Divestitures (2020)
Selectis Health (GBCS) posted Gains from Sales and Divestitures of $7500.0 for Q4 2020.
Selectis Health (GBCS) Gains from Sales and Divestitures (2020) Analysis & Trends
Selectis Health (GBCS) has 1 years of Gains from Sales and Divestitures data on file, last reported at $7500.0 in Q4 2020.
- Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $7500.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $7500.0 (changed N/A YoY) and the FY2020 annual result came in at $7500.0, changed N/A from the prior year.
- Gains from Sales and Divestitures was little changed at $7500.0 in Q4 2020 per GBCS's latest filing.
- The five-year high for Gains from Sales and Divestitures was $7500.0 in Q4 2020, with the low at $7500.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn |
| 10 | Selectis Health | 15.98 Mn | 14.97 Mn | 2.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 7,500.00 |
| Dec 31, 2020 | 7,500.00 |